Search Results
44 results
Your search is now limited to «Clinical Trials» expert search.
PR Newswire 01/17/2019 08:00
The HOPE4MCI study builds on an earlier Phase 2 clinical trial[1] that evaluated the efficacy of AGB101 on reducing hippocampal overactivity and on improving episodic memory, the earliest memory impairment in MCI due to AD.
More from PR Newswire:
Benzinga 12/18/2018 08:30
Lumateperone is under review by the FDA for the treatment of schizophrenia and is in Phase 3 clinical development for the treatment of bipolar depression.
More from Benzinga:
Eisai said that the first investigational drug candidate from its drug discovery collaboration with University College London (UCL) is set to enter Phase I clinical trials for Alzheimer's disease (AD) in early 2019.
More from Pharmaceutical Business Review:
GlobeNewswire 12/06/2018 07:30
In mid-2019, the Company expects to conduct a Phase IIb study in 36 patients with Alzheimer’s treated with PTI-125 for 3 months.
More from GlobeNewswire:
JCN Newswire 12/05/2018 20:58
Significant unmet medical needs exist for neurodegenerative disorders such as Alzheimer's disease due to a lack of effective treatments that can prevent disease progression, and Eisai's mission is to contribute to overcoming these issues.
More from JCN Newswire:
WN.com 11/27/2018 08:42
SAINT LAURENT, Quebec, Nov. 27, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the 'Company' or 'IntelGenx') today announced that patient dosing has commenced in the Phase 2a study of Montelukast VersaFilm™ in patients with mild to moderate Alzheimer's Disease (AD).
More from WN.com:
Business Wire 11/15/2018 07:00
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Alector has initiated its Phase 1 INVOKE study, investigating the company’s 2nd product candidate, AL002, for the treatment of Alzheimer's disease.
More from Business Wire:
This 'phase flexibility' is called a ‘Direct-to-Phase II’ SBIR award.
More from National Institutes of Health (NIH):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications